|
Market Closed -
Nasdaq
06:00:00 16/09/26 am AEST
|
5-day change | 1st Jan Change | ||
| 7.160 USD | +0.42% |
|
-13.11% | +128.03% |
| 11/09 | Agenus Inc. - Shareholder/Analyst Call | |
| 10/09 | Agenus Inc. Presents Three-Year Overall Survival Data for Botensilimab Plus Balstilimab in Recurrent Ovarian Cancer | CI |
| Market Cap | 322M 279M 264M 239M 449M 30.9B 452M 3.15B 1.21B 15.67B 1.21B 1.18B 50.02B | P/E 2026 * |
10.5x | P/E 2027 * | -29.2x |
|---|---|---|---|---|---|
| Enterprise Value | 322M 279M 264M 239M 449M 30.9B 452M 3.15B 1.21B 15.67B 1.21B 1.18B 50.02B | EV / Sales 2026 * |
2.3x | EV / Sales 2027 * | 2.35x |
| Free-Float |
93.77% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| AGEN | Delayed | |
CBOE
| AGEN | Real-time | |
|
Tradegate
| AJ8 | Real-time | |
|
Deutsche Boerse AG
| AJ8 | Delayed | |
|
Boerse Muenchen
| AJ8 | Real-time |
Last Transcript: Agenus Inc.
| 1 day | +0.42% | ||
| 1 week | -13.11% | ||
| Current month | -5.91% | ||
| 1 month | -2.19% | ||
| 3 months | +116.97% | ||
| 6 months | +130.97% | ||
| Current year | +128.03% |
| 1 week | 6.66 |  | 7.6 |
| 1 month | 6.66 | | 8.73 |
| Current year | 2.71 | | 8.85 |
| 1 year | 2.71 | | 8.85 |
| 3 years | 1.38 | | 25.8 |
| 5 years | 1.38 | | 123.9 |
| 10 years | 1.38 | | 149.8 |
| Manager | Title | Age | Since |
|---|---|---|---|
Garo Armen
CEO | Chief Executive Officer | 73 | 31/03/1994 |
Kamel Djazouli
CTO | Chief Tech/Sci/R&D Officer | - | - |
Craig Winter
CTO | Chief Tech/Sci/R&D Officer | - | 01/11/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
Garo Armen
CHM | Chairman | 73 | 04/11/2010 |
Brian Corvese
BRD | Director/Board Member | 68 | 08/03/2007 |
Timothy Wright
BRD | Director/Board Member | 68 | 07/12/2006 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 10/8/26 | Free | Chief Executive Officer | 1,971,500 | 4.4054% | ||
| 5/8/26 | Free | Director | 50,000 | 0.1117% | ||
| 5/8/26 | Free | Director | 50,000 | 0.1117% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.42% | -13.11% | +59.82% | -72.46% | 321M | |
| +0.56% | -4.17% | -1.90% | +9.79% | 45.63B | |
| -0.12% | -2.46% | +340.09% | +529.37% | 43.96B | |
| +1.51% | +0.71% | +44.04% | +26.63% | 43.73B | |
| -2.07% | -3.28% | +6.83% | +74.56% | 40.23B | |
| -0.73% | -4.72% | +8.55% | +37.89% | 31.86B | |
| -9.49% | -11.38% | - | - | 17.4B | |
| +4.21% | +4.94% | +26.46% | +121.58% | 16.62B | |
| +1.83% | +2.63% | +15.14% | +33.31% | 14.46B | |
| -0.08% | -5.41% | +78.48% | +31.34% | 13.04B | |
| Average | +0.61% | -2.98% | +64.17% | +88.00% | 26.72B | |
| Weighted average by Cap. | +0.51% | -2.11% | +76.20% | +127.99% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 140M 122M 115M 104M 195M 13.45B 197M 1.37B 528M 6.82B 527M 515M 21.77B | 137M 119M 112M 102M 191M 13.16B 193M 1.34B 517M 6.68B 516M 504M 21.31B |
| Net income | 35.2M 30.51M 28.83M 26.13M 48.99M 3.37B 49.39M 344M 132M 1.71B 132M 129M 5.46B | -26.1M -22.62M -21.37M -19.37M -36.33M -2.5B -36.62M -255M -98.15M -1.27B -98.03M -95.85M -4.05B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 15/09/26 | USD 7.160 | +0.42% | 779,381 |
| 14/09/26 | USD 7.130 | +2.74% | 752,308 |
| 11/09/26 | USD 6.940 | +0.73% | 790,464 |
| 10/09/26 | USD 6.890 | +0.44% | 893,555 |
| 09/09/26 | USD 6.860 | -7.67% | 1,445,780 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- AGEN Stock
Select your edition
All financial news and data tailored to specific country editions
